History
  • No items yet
midpage
Bristol-Myers Squibb Co. v. Superior Court of San Francisco County
206 Cal. Rptr. 3d 636
Cal.
2016
Read the full case

Background

  • Bristol-Myers Squibb (BMS), incorporated in Delaware and headquartered in New York, marketed and sold the drug Plavix nationwide and had substantial operations in California (research labs, ~164 employees, ~250 sales reps, ~$918M Plavix sales in CA 2006–2012).
  • Eight coordinated state-court complaints in San Francisco named 678 plaintiffs: 86 California residents and 592 nonresidents, asserting product-liability, fraud, misrepresentation, unfair competition, and related claims arising from Plavix.
  • BMS moved to quash service as to the 592 nonresident plaintiffs, arguing California courts lack personal jurisdiction over out-of-state claims that neither arose in nor were connected to California.
  • Trial court denied the motion (concluding general jurisdiction). Court of Appeal (after Daimler) held no general jurisdiction but upheld specific jurisdiction over nonresident claims. California Supreme Court granted review.
  • The high‑court majority (Cantil‑Sakauye, C.J.) affirmed the Court of Appeal: no general jurisdiction under Daimler’s “at home” rule, but specific jurisdiction exists because BMS purposefully availed itself of California and the nonresident claims are substantially connected to BMS’s California contacts; exercising jurisdiction is reasonable.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
General jurisdiction: Is BMS "at home" in CA? Plaintiffs: BMS’s extensive CA operations and sales make CA a forum for all claims. BMS: Incorporated elsewhere, HQ elsewhere, CA contacts insufficient under Goodyear/Daimler. No general jurisdiction — BMS not "at home" in California.
Specific jurisdiction — purposeful availment: Did BMS purposefully direct activities at CA? Plaintiffs: Yes — nationwide marketing, large CA sales, CA salesforce, CA distributor, R&D presence. BMS: Contacts insufficiently tied to nonresidents’ out‑of‑state injuries. Yes — BMS purposefully availed itself of CA forum.
Specific jurisdiction — relatedness: Do nonresident claims arise from or relate to BMS’s CA contacts? Plaintiffs: Claims stem from a single nationwide course of conduct (design, marketing, distribution) that includes CA activities; thus claims bear a substantial connection to CA. BMS: Nonresidents’ injuries occurred outside CA; CA contacts do not substantially connect to those claims. Yes — under Vons sliding‑scale test, nationwide marketing + CA R&D/sales create a substantial nexus.
Specific jurisdiction — reasonableness: Would asserting jurisdiction offend fair play and substantial justice? Plaintiffs: Forum is reasonable; judicial economy, CA interest in protecting consumers and in regulating CA distributor, and convenience favor CA. BMS: Unfair burden to defend hundreds of nonresident claims in CA; other forums more appropriate; federalism concerns. Yes — court balances factors and finds exercising specific jurisdiction reasonable; BMS did not carry burden to show unreasonableness.

Key Cases Cited

  • International Shoe Co. v. Washington, 326 U.S. 310 (establishes minimum‑contacts test for due process)
  • Goodyear Dunlop Tires Operations, S.A. v. Brown, 564 U.S. 915 (limits general jurisdiction; introduces "at home" concept)
  • Daimler AG v. Bauman, 571 U.S. 117 (clarifies that general jurisdiction is confined to forums where a corporation is "at home")
  • Vons Companies, Inc. v. Seabest Foods, Inc., 14 Cal.4th 434 (adopts sliding‑scale substantial‑connection test for relatedness in specific jurisdiction)
  • Walden v. Fiore, 571 U.S. 277 (emphasizes that due process protects defendant’s liberty and that contacts must be the defendant’s own)
Read the full case

Case Details

Case Name: Bristol-Myers Squibb Co. v. Superior Court of San Francisco County
Court Name: California Supreme Court
Date Published: Aug 29, 2016
Citation: 206 Cal. Rptr. 3d 636
Docket Number: S221038
Court Abbreviation: Cal.